EMILIN1 deficiency causes arterial tortuosity with osteopenia and connects impaired elastogenesis with defective collagen fibrillogenesis

dc.authorid0000-0003-1472-1397
dc.authorid0000-0002-8560-6153
dc.authorid0000-0003-1488-3695
dc.authorid0000-0003-0872-3898
dc.authorid0000-0001-6940-9240
dc.authorid0000-0002-5604-7639
dc.contributor.authorAdamo, Christin S.
dc.contributor.authorBeyens, Aude
dc.contributor.authorSchiavinato, Alvise
dc.contributor.authorKeene, Douglas R.
dc.contributor.authorTufa, Sara F.
dc.contributor.authorMorgelin, Matthias
dc.contributor.authorBrinckmann, Jurgen
dc.date.accessioned2025-05-10T19:48:27Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractEMILIN1 (elastin-microfibril-interface-located-protein-1) is a structural component of the elastic fiber network and localizes to the inter-face between the fibrillin microfibril scaffold and the elastin core. How EMILIN1 contributes to connective tissue integrity is not fully understood. Here, we report bi-allelic EMILIN1 loss-of-function variants causative for an entity combining cutis laxa, arterial tortuosity, aneurysm formation, and bone fragility, resembling autosomal-recessive cutis laxa type 1B, due to EFEMP2 (FBLN4) deficiency. In both humans and mice, absence of EMILIN1 impairs EFEMP2 extracellular matrix deposition and LOX activity resulting in impaired elasto-genesis, reduced collagen crosslinking, and aberrant growth factor signaling. Collagen fiber ultrastructure and histopathology in EMILIN1-or EFEMP2-deficient skin and aorta corroborate these findings and murine Emilin1-/- femora show abnormal trabecular bone formation and strength. Altogether, EMILIN1 connects elastic fiber network with collagen fibril formation, relevant for both bone and vascular tissue homeostasis.
dc.description.sponsorshipDeutsche Forschungsgemeinschaft (DFG, German Research Foundation) [397484323 ( TRR 259/B09), 73111208 ( SFB 829/B12), 384170921 (FOR2722/B1), FOR2722/D1, FOR2722/C2]; Special Research Fund of Ghent University [01N04516C, BOF21/ GOA/019]; Research Foundation - Flanders (FWO) [G035620N]; European Academy of Dermatology and Venereology [PPRC-2018-50]
dc.description.sponsorshipMass spectrometric analysis and statistical evaluation was performed by Dr. Stefan Muller (CECAD Proteomics Facility). TEM-analysis of murine samples was carried out by Beatrix Martiny, C.S.A., and G.S. in the CECAD Imaging Facility. TEM-analysis of human samples was conducted by M.D.B., F.B., A.B., and R.D.R. in the VIB-Bioimaging Core. TEM analysis of fibroblast supernatants was performed by M.M. EM analyses of biopsies from family 4 were carried out by D.R.K. We are grateful to the staff in the BioEM Lab, Biozentrum, University of Basel, and the Core Facility for Integrated Microscopy (CFIM), Panum Institute, University of Copenhagen, for providing highly innovative environments for electron microscopy. We thank Carola Alampi (BioEM lab), Mohamed Chami (BioEM lab), and Klaus Qvortrup (FCIM) for practical help with electron microscopy. Funding for this study was provided by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) project numbers 397484323 ( TRR 259/B09), 73111208 ( SFB 829/B12), and 384170921 (FOR2722/B1 to R.W. and M.P., FOR2722/D1 to A. N., and FOR2722/C2 to G. S.). B.C. is a senior clinical investigator of the Research Foundation Flanders. This work was supported by grants of the Special Research Fund of Ghent University (grant 01N04516C and BOF21/ GOA/019 to B.C.), a research grant G035620N of the Research Foundation - Flanders (FWO) to B.C., and a research grant of European Academy of Dermatology and Venereology (PPRC-2018-50) to B.C. Ghent University Hospital is a member of the European Reference Network for Skin Disorders (ERN-Skin), intellectual disability, tele-health, autism and congenital abnormalities (ERN-ITHACA) and vascular abnormalities (VascERN).
dc.identifier.doi10.1016/j.ajhg.2022.10.010
dc.identifier.endpage2252
dc.identifier.issn0002-9297
dc.identifier.issn1537-6605
dc.identifier.issue12
dc.identifier.pmid36351433
dc.identifier.scopus2-s2.0-85143380065
dc.identifier.scopusqualityQ1
dc.identifier.startpage2230
dc.identifier.urihttps://doi.org/10.1016/j.ajhg.2022.10.010
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11694
dc.identifier.volume109
dc.identifier.wosWOS:000905285200014
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherCell Press
dc.relation.ispartofAmerican Journal of Human Genetics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectOligomeric Matrix Protein
dc.subjectCutis Laxa
dc.subjectLysyl Oxidase
dc.subjectElastic Fibers
dc.subjectFibulin-4
dc.subjectFibrillin
dc.subjectMaturation
dc.subjectBone
dc.subjectGene
dc.subjectThrombospondin-5
dc.titleEMILIN1 deficiency causes arterial tortuosity with osteopenia and connects impaired elastogenesis with defective collagen fibrillogenesis
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11694.pdf
Boyut:
8.56 MB
Biçim:
Adobe Portable Document Format